|
Market Closed -
Australian S.E.
01:10:13 2026-10-29 am EDT
|
5-day change | 1st Jan Change | ||
| 1.050 AUD | +3.96% |
|
+13.51% | +150.00% |
| Market Cap | 233M 164M 147M 136M 123M 230M 15.6B 1.62B 647M 8.16B 614M 602M 25.91B | P/E 2025 |
17.8x | P/E 2026 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 228M 160M 144M 133M 120M 225M 15.27B 1.59B 633M 7.99B 602M 589M 25.37B | EV / Sales 2025 |
2.82x | EV / Sales 2026 | 2.82x |
| Free-Float |
41.81% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| BLS | Delayed | |
Deutsche Boerse AG
| PR80 | Delayed | |
|
Boerse Muenchen
| PR80 | Real-time |
Last Transcript: BLS Pharmaceuticals Limited
| 1 day | +3.96% | ||
| 1 week | +13.51% | ||
| 1 month | +5.53% | ||
| 3 months | +34.62% | ||
| 6 months | +75.00% | ||
| Current year | +150.00% |
| 1 week | 0.9 |  | 1.05 |
| 1 month | 0.9 | | 1.13 |
| Current year | 0.36 | | 1.3 |
| 1 year | 0.35 | | 1.3 |
| 3 years | 0.04 | | 1.3 |
| 5 years | 0.04 | | 1.3 |
| 10 years | 0.04 | | 1.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Watson
CEO | Chief Executive Officer | - | 2023-05-18 |
Guy Robertson
DFI | Director of Finance/CFO | 72 | 2016-08-31 |
Jason Hine
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peng Ho
CHM | Chairman | 67 | 2012-12-04 |
Guy Robertson
BRD | Director/Board Member | 72 | 2022-06-29 |
Sam Watson
BRD | Director/Board Member | - | 2023-05-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/14/26 | Buy | 5,000,000 | 0.2202% | |||
| 5/14/26 | Exercice | 5,000,000 | 0.2202% | |||
| 3/22/26 | Buy | Chief Executive Officer | 1,800,000 | 0.0804% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.96% | +13.51% | +156.10% | +775.00% | 164M | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,148B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 652B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 505B | |
| -0.05% | +1.73% | +52.74% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 348B | |
| +0.34% | +1.84% | +30.70% | +54.27% | 294B | |
| -0.45% | +1.19% | +2.89% | +26.08% | 264B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 244B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +0.53% | +2.17% | +52.19% | +146.26% | 403.73B | |
| Weighted average by Cap. | +0.26% | +1.50% | +44.53% | +89.13% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 29.28M 20.61M 18.49M 17.1M 15.49M 28.93M 1.96B 204M 81.43M 1.03B 77.35M 75.72M 3.26B | 73.91M 52.03M 46.68M 43.16M 39.09M 73.03M 4.96B 516M 206M 2.59B 195M 191M 8.23B |
| Net income | 4.9M 3.45M 3.1M 2.86M 2.59M 4.84M 329M 34.22M 13.63M 172M 12.95M 12.67M 546M | 15.4M 10.84M 9.72M 8.99M 8.14M 15.21M 1.03B 107M 42.82M 540M 40.67M 39.82M 1.71B |
| Net Debt | -6.13M -4.32M -3.87M -3.58M -3.24M -6.06M -411M -42.83M -17.06M -215M -16.2M -15.86M -683M | -4.86M -3.42M -3.07M -2.84M -2.57M -4.8M -326M -33.9M -13.5M -170M -12.83M -12.56M -541M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | A$1.050 | +3.96% | 166,067 |
| 26-10-28 | A$1.010 | +1.00% | 121,404 |
| 26-10-27 | A$1.000 | +5.26% | 354,839 |
| 26-10-26 | A$0.9500 | +1.60% | 232,650 |
| 26-10-23 | A$0.9350 | +1.08% | 269,679 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BLS Stock
Select your edition
All financial news and data tailored to specific country editions
